CD19 and acute myeloid leukemia: Bone marrow immunophenotypic analyses revealed 23% blasts; positivity for CD34, HLADR and CD33; and negativity for CD7, CD19, CD10, CD117, CD36 and CD15, characterizing acute myeloid leukemia (AML), FAB classification M4.